Pretreatment with empagliflozin attenuated AKI, defined by elevation of renal NGAL and KIM-1 levels, after MI in OLETF in a manner similar to that of pretreatment with canagliflozin4. This evidence concerns the gene HAVCR1 and acute kidney injury.